Secondary Logo

Journal Logo

Published Ahead-of-Print - Last Updated: August 03, 2020

The editors of this journal are pleased to offer electronic publication of accepted papers prior to print publication. These papers can be cited using the date of access and the unique DOI number. Any final changes in manuscripts will be made at the time of print publication and will be reflected in the final electronic version of the issue.

Disclaimer: Articles appearing in this Published Ahead-of-Print section have been peer-reviewed and accepted for publication in this journal and posted online before print publication. Articles appearing here may contain statements, opinions, and information that have errors in facts, figures, or interpretation. Accordingly, Lippincott Williams & Wilkins, the editors and authors and their respective employees are not responsible or liable for the use of any such inaccurate or misleading data, opinion or information contained in the articles in this section.

Published Ahead-of-Print Articles are available in PDF format only.

PDF Only

PDF Only

PDF Only

Effect of the neurokinin 3 receptor antagonist fezolinetant on patient-reported outcomes in postmenopausal women with vasomotor symptoms: results of a randomized, placebo-controlled, double-blind, dose-ranging study (VESTA)

Santoro, Nanette; Waldbaum, Arthur; Lederman, Samuel; More

Menopause. Post Author Corrections: August 03, 2020

Effects of pharmacologic and nonpharmacologic interventions on menopause-related quality of life: a pooled analysis of individual participant data from four MsFLASH trials

Diem, Susan J.; LaCroix, Andrea Z.; Reed, Susan D.; More

Menopause. Post Author Corrections: July 20, 2020

TX-001HR is associated with a clinically meaningful effect on severity of moderate to severe vasomotor symptoms in the REPLENISH trial

Constantine, Ginger D.; Simon, James A.; Kaunitz, Andrew M.; More

Menopause. Post Author Corrections: July 13, 2020

The association between weight-promoting medication use and weight gain in postmenopausal women: findings from the Women's Health Initiative

Stanford, Fatima Cody; Cena, Hellas; Biino, Ginevra; More

Menopause. Post Author Corrections: July 13, 2020

A proprotein convertase subtilisin/kexin type 9 inhibitor provides comparable efficacy with lower detriment than statins on mitochondria of oxidative muscle of obese estrogen-deprived rats

Thonusin, Chanisa; Pantiya, Patcharapong; Jaiwongkam, Thidarat; More

Menopause. Post Author Corrections: June 22, 2020

Doctor, ask your perimenopausal patient about her physical fitness; association of self-reported physical fitness with cardiometabolic and mental health in perimenopausal women: the FLAMENCO project

Aparicio, Virginia A.; Marín-Jiménez, Nuria; Coll-Risco, Irene; More

Menopause. Post Author Corrections: September 09, 2019

PDF Only

PDF Only

PDF Only

Variation in outcome reporting and measurement tools in clinical trials of treatments for genitourinary symptoms in peri- and postmenopausal women: a systematic review

Christmas, Monica Michelle; Song, Bonnie; Bell, Robin J.; More

Menopause. Post Author Corrections: July 13, 2020

Effects of phytoestrogen supplementation on intermediate cardiovascular disease risk factors among postmenopausal women: a meta-analysis of randomized controlled trials

Wolters, Maike; Dejanovic, Gordana M.; Asllanaj, Eralda; More

Menopause. Post Author Corrections: June 29, 2020

PDF Only

PDF Only

PDF Only

The menopause transition and women's health at midlife: a progress report from the Study of Women's Health Across the Nation (SWAN)

El Khoudary, Samar R.; Greendale, Gail; Crawford, Sybil L.; More

Menopause. Post Author Corrections: September 23, 2019